Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Titel:
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Auteur:
Yang, Shilong Li, Yan Dai, Lianpan Wang, Jianfeng He, Peng Li, Changgui Fang, Xin Wang, Chenfei Zhao, Xiang Huang, Enqi Wu, Changwei Zhong, Zaixin Wang, Fengze Duan, Xiaomin Tian, Siyu Wu, Lili Liu, Yan Luo, Yi Chen, Zhihai Li, Fangjun Li, Junhua Yu, Xian Ren, Hong Liu, Lihong Meng, Shufang Yan, Jinghua Hu, Zhongyu Gao, Lidong Gao, George F